Trademark Overview
On Friday, January 20, 2023, a trademark application was filed for ELXR with the United States Patent and Trademark Office. The USPTO has given the ELXR trademark a serial number of 97761836. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, August 7, 2023. This trademark is owned by Scribe Therapeutics Inc.. The ELXR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, diagnostic and therapeutic products and services; Design and development of engineered cells for use in scientific research and drug discovery and development; Providing medical research and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering
